294 filings
Page 4 of 15
CORRESP
gw5m2e 6x
6 Jul 22
Correspondence with SEC
12:00am
UPLOAD
677e80ewrxq1
29 Jun 22
Letter from SEC
12:00am
8-K
c3k8j8as4axfrwb
6 Jun 22
Corporate Presentation June 2022
7:58am
8-K
gd6d4iv609r0tp1wj6
16 May 22
Submission of Matters to a Vote of Security Holders
4:25pm
EFFECT
qhuo hu3nsif
7 Apr 22
Notice of effectiveness
12:15am
8-K
z65sxv uibqdnku29
30 Mar 22
Entry into a Material Definitive Agreement
8:19am
POS AM
haigc cm0y3
28 Mar 22
Prospectus update (post-effective amendment)
5:43pm
POSASR
3o9znki6vgq
28 Mar 22
Automatic shelf registration (post-effective amendment)
4:05pm
8-K
5w7awzr5otkq3060bl4h
28 Mar 22
Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors
8:03am
8-K
k2admq4ii4mq
11 Jan 22
Corporate Presentation January 2022
4:15pm
8-K
i0tu9q62 ikt
26 Oct 21
Verastem Oncology Appoints Michelle Robertson to Board of Directors
8:12am
424B5
imqk3 gbmi
2 Aug 21
Prospectus supplement for primary offering
5:15pm
S-3ASR
1eusj2wfe2g153n
2 Aug 21
Automatic shelf registration
4:43pm
8-K
nlj5xye
24 Jun 21
Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
7:41am
S-8
lmhsi7m0xw4c8p
15 Jun 21
Registration of securities for employees
2:32pm